• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Illumina expects EU order to keep Grail a separate company

September 20, 2021 by David Barret Leave a Comment

September 20, 2021

By Foo Yun Chee

BRUSSELS (Reuters) -Illumina Inc expects an EU order to keep recently acquired Grail Inc as a separate company, the U.S. life sciences company said on Monday, hours after EU antitrust regulators warned of interim measures for closing the deal before their approval.

The company is likely to face other measures on top of the hold separate order, however, with the EU competition enforcer sending a warning to other companies.

Illumina finalised the Grail takeover last month and said it would hold the company separate while waiting for a European Commission decision on the deal, defying EU merger rules against gun-jumping.

Previous instances of gun-jumping have resulted in companies being hit with million-euro fines. Sanctions can be as much as 10% of a company’s global turnover.

“We had anticipated that the Commission would seek to impose a hold separate order, and this is the reason why it has already voluntarily agreed to such an arrangement; their proposals are based on Illumina’s voluntary undertakings,” Illumina said in a statement.

It said it would discuss certain changes suggested by the EU in the coming days.

The EU competition enforcer earlier on Monday said it had sent a statement of objections or charge sheet to the companies, setting out the interim measures it plans to take. It did not provide details.

Under EU merger rules, the competition watchdog can order companies to unwind their deals or sell off shares or assets acquired for violations.

Commission Vice-President Margrethe Vestager underlined the seriousness of Illumina’s actions, saying it was the first time companies had openly implemented a deal while regulators were still investigating.

“The standstill obligation is a cornerstone of our ex-ante merger control regime which aims at preventing harmful effects to competition while our review is ongoing,” she said in a statement.

The Commission said the interim measures aim to restore and maintain effective competition pending a final decision on the deal.

The Commission will make a final decision on the measures after receiving the companies’ response.

(Reporting by Foo Yun Chee in BrusselsEditing by Jan Harvey and Matthew Lewis)

Source Link Illumina expects EU order to keep Grail a separate company

David Barret
David Barret

Related posts:

  1. Lebanon agrees new government to tackle economic collapse
  2. India, Australia eye closer security ties as 9/11 anniversary marked
  3. Motor racing-Mercedes boss says F1 sprint format is ‘not fish, not meat’
  4. In Hungary, pope says anti-Semitism ‘fuse’ must not be allowed to burn

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • A Giant Volcano Off The Coast Of Oregon Is Scheduled To Erupt In 2026, JWST Finds The Best Evidence Yet Of A Lava World With A Thick Atmosphere, And Much More This Week
  • The UK’s Tallest Bird Faced Extinction In The 16th Century. Now, It’s Making A Comeback
  • Groundbreaking Discovery Of Two MS Subtypes Could Lead To New Targeted Treatments
  • “We Were So Lucky To Be Able To See This”: 140-Year Mystery Of How The World’s Largest Sea Spider Makes Babies Solved
  • China To Start New Hypergravity Centrifuge To Compress Space-Time – How Does It Work?
  • These Might Be The First Ever Underwater Photos Of A Ross Seal, And They’re Delightful
  • Mysterious 7-Million-Year-Old Ape May Be Earliest Hominin To Walk On Two Feet
  • This Spider-Like Creature Was Walking Around With A Tail 100 Million Years Ago
  • How Do GLP-1 Agonists Like Ozempic and Wegovy Work?
  • Evolution In Action: These Rare Bears Have Adapted To Be Friendlier And Less Aggressive
  • Nearly 100 Years After Debating Bohr On Quantum Mechanics, New Experiment Proves Einstein Wrong – Again
  • 9,500-Year-Old Headless Skeleton Is New World’s Oldest Known Cremated Adult
  • World’s Longest Jellyfish Can Reach A Whopping 36 Meters, Even Bigger Than A Blue Whale
  • In 1994, December 31 Was Wiped From Existence In Kiribati
  • A Giant Volcano Off The Coast Of Oregon Failed To Erupt On Time. Its New Schedule: 2026
  • Here Are 5 Ways In Which Cancer Treatment Advanced In 2025
  • The First Marine Mammal Driven To Extinction By Humans Disappeared Only 27 Years After Being Discovered
  • The Planet’s Oldest Bee Species Has Become The World’s First Insect To Be Granted Legal Rights
  • Facial Disfiguration: Why Has The Face Been The Target Of Punishment Across Time?
  • The World’s Largest Living Reptile Can “Surf” Over 10 Kilometers To Get Between Islands
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2026 · Medical Market Report. All Rights Reserved.

Go to mobile version